Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Hepatitis

  Free Subscription


Articles published in J Interferon Cytokine Res

Retrieve available abstracts of 32 articles:
HTML format



Single Articles


    February 2020
  1. ABOUELASRAR SALAMA S, Gouwy M, De Zutter A, Portner N, et al
    Induction of Chemokines by Hepatitis C Virus Proteins: Synergy of the Core Protein with Interleukin-1beta and Interferon-gamma in Liver Bystander Cells.
    J Interferon Cytokine Res. 2020 Feb 7. doi: 10.1089/jir.2019.0115.
    PubMed     Abstract available


    January 2020
  2. WAHID B
    Clinical Correlation of Blood Cells with Suppression of Cytokine Signaling Gene Expression in Hepatitis C Virus-Infected Patients.
    J Interferon Cytokine Res. 2020 Jan 27. doi: 10.1089/jir.2019.0116.
    PubMed     Abstract available


    December 2019
  3. HU CC, Weng CH, Hua MC, Chang PH, et al
    New Scoring Method to Predict Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C after Pegylated Interferon and Ribavirin Therapy.
    J Interferon Cytokine Res. 2019 Dec 3. doi: 10.1089/jir.2019.0103.
    PubMed     Abstract available


    July 2019
  4. NING L, Huang X, Xu Y, Yang G, et al
    Boosting of Hepatitis B Virus-Specific T Cell Responses After Pegylated-Interferon-alpha-2a Therapy for Hepatitis B e Antigen-Positive Pediatric Patients.
    J Interferon Cytokine Res. 2019 Jul 18. doi: 10.1089/jir.2019.0042.
    PubMed     Abstract available


  5. PEDERGNANA V, Irving WL, Barnes E, McLauchlan J, et al
    Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
    J Interferon Cytokine Res. 2019 Jul 1. doi: 10.1089/jir.2019.0013.
    PubMed     Abstract available


    June 2019
  6. NA SK, Lee SJ, Cho YK, Kim YN, et al
    Aspartate Aminotransferase-to-Platelet Ratio or Fibros-4 Index Predicts the Development of Hepatocellular Carcinoma in Chronic Hepatitis C Patients with Sustained Virologic Response to Interferon Therapy.
    J Interferon Cytokine Res. 2019 Jun 19. doi: 10.1089/jir.2019.0049.
    PubMed     Abstract available


  7. ABOUSHADY M, Alwassief A, Abdelrazik M, Ziada D, et al
    Retreatment of Egyptian Chronic Hepatitis C Patients Not Responding to Pegylated Interferon and Ribavirin Dual Therapy.
    J Interferon Cytokine Res. 2019 Jun 6. doi: 10.1089/jir.2019.0041.
    PubMed     Abstract available


  8. O'BRIEN TR, Jackson SS
    What Have We Learned from Studies of IFN-lambda Variants and HCV Infection?
    J Interferon Cytokine Res. 2019 Jun 4. doi: 10.1089/jir.2019.0048.
    PubMed     Abstract available


    April 2019

  9. Correction to: Hepatic IFN-Induced Protein with Tetratricopeptide Repeats Regulation of HCV Infection by Ishida Y, Kakuni M, Bang B-R, Sugahara G, Lau DT-Y, Tateno-Mukaidani C, Li M, Gale M Jr., and Saito T. J Interferon Cytokine Res. 2019;39(3):133-1
    J Interferon Cytokine Res. 2019 Apr 16. doi: 10.1089/jir.2018.0103.
    PubMed    


    March 2019
  10. WAHID B
    Role of SOCS1 Gene in Chronic Hepatitis C Virus Patients: A Mini-Review.
    J Interferon Cytokine Res. 2019 Mar 27. doi: 10.1089/jir.2018.0109.
    PubMed     Abstract available


  11. HU JH, Chang ML, Huang TJ, Yeh CT, et al
    Comparison of Compliance and Efficacy of Pegylated Interferon alpha-2a and alpha-2b in Adults with Chronic Hepatitis C.
    J Interferon Cytokine Res. 2019 Mar 11. doi: 10.1089/jir.2018.0028.
    PubMed     Abstract available


  12. ISHIDA Y, Kakuni M, Bang BR, Sugahara G, et al
    Hepatic IFN-Induced Protein with Tetratricopeptide Repeats Regulation of HCV Infection.
    J Interferon Cytokine Res. 2019;39:133-146.
    PubMed     Abstract available


    January 2019
  13. HUANG N, Ji FP, Zhang S, Li Z, et al
    Spleen-Associated Effects on Immunity in Hepatitis B Virus-Related Cirrhosis with Portal Hypertension.
    J Interferon Cytokine Res. 2019 Jan 24. doi: 10.1089/jir.2018.0121.
    PubMed     Abstract available


  14. MONTASSER MF, Zaky S, Salaheldin M, Johar D, et al
    Fib-4 Predicts Early Hematological Adverse Events Induced by Interferon-Based Triple Therapy in Chronic Hepatitis C Virus Patients.
    J Interferon Cytokine Res. 2019 Jan 18. doi: 10.1089/jir.2018.0131.
    PubMed     Abstract available


    October 2018
  15. WANG JW, Wang JW, Zhang J, Wu CS, et al
    Decreased Methylation of IFNAR Gene Promoter from Peripheral Blood Mononuclear Cells Is Associated with Oxidative Stress in Chronic Hepatitis B.
    J Interferon Cytokine Res. 2018 Oct 31. doi: 10.1089/jir.2018.0068.
    PubMed     Abstract available


    August 2018
  16. ABD EL-MEGUID M, Dawood RM, Mokhles MA, El Awady MK, et al
    Extrahepatic Upregulation of Transforming Growth Factor Beta 2 in HCV Genotype 4-Induced Liver Fibrosis.
    J Interferon Cytokine Res. 2018;38:341-347.
    PubMed     Abstract available


    July 2018
  17. COOKSLEY H, Riva A, Katzarov K, Hadzhiolova-Lebeau T, et al
    Differential Expression of Immune Inhibitory Checkpoint Signatures on Antiviral and Inflammatory T Cell Populations in Chronic Hepatitis B.
    J Interferon Cytokine Res. 2018;38:273-282.
    PubMed     Abstract available


    June 2018
  18. NAZ Z, Wahid B, Usman S, Saleem K, et al
    Expression of SOCS1 and SOCS3 Genes in Interferon-Treated and Direct-Acting Antiviral Drugs-Treated Hepatitis C Patients.
    J Interferon Cytokine Res. 2018;38:255-260.
    PubMed     Abstract available


    May 2018
  19. CAO WH, Li MH, Pan CQ, Lu Y, et al
    Quantitation of Plasmacytoid Dendritic Cells in Chronic Hepatitis B Patients with HBeAg Positivity During PEG-IFN and Entecavir Therapy.
    J Interferon Cytokine Res. 2018;38:197-205.
    PubMed     Abstract available


    March 2018
  20. EL-RAZIKY M, Khairy M, Fouad A, Salama A, et al
    Effect of Direct-Acting Agents on Fibrosis Regression in Chronic Hepatitis C Virus Patients' Treatment Compared with Interferon-Containing Regimens.
    J Interferon Cytokine Res. 2018;38:129-136.
    PubMed     Abstract available


  21. WAHID B, Rafique S, Saleem K, Ali A, et al
    An Increase in Expression of SOCS1 Gene with Increase in Hepatitis C Virus Viral Load.
    J Interferon Cytokine Res. 2018;38:122-128.
    PubMed     Abstract available


    February 2018
  22. ZAREBSKA-MICHALUK D, Flisiak R, Jaroszewicz J, Janczewska E, et al
    Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?
    J Interferon Cytokine Res. 2018;38:93-100.
    PubMed     Abstract available


    January 2018
  23. EL KASSAS M, Omran D, Elsaeed K, Alboraie M, et al
    Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience.
    J Interferon Cytokine Res. 2018 Jan 22. doi: 10.1089/jir.2017.0121.
    PubMed     Abstract available


  24. ALEZZI ZMM, Abd El Rehim AY, Fathallah WF, Alamrani MA, et al
    Factors Affecting the Virological Response Among Chronic Hepatitis C Virus Patients in Yemen.
    J Interferon Cytokine Res. 2018;38:38-44.
    PubMed     Abstract available


    November 2017
  25. ALTRAIF IH, Sanai F, Babatin MA, Alalwan AA, et al
    Pharmacokinetics-Based Adjusted Versus Standard Dose of Ribavirin Does Not Improve Virologic Response Rates in Chronic Hepatitis C Genotype 4 Patients: A Randomized Controlled Trial.
    J Interferon Cytokine Res. 2017;37:488-493.
    PubMed     Abstract available


    July 2017
  26. JI F, Zhou R, Wang W, Bai D, et al
    High Post-treatment alpha-Fetoprotein Levels and Aspartate Aminotransferase-to-Platelet Ratio Index Predict Hepatocellular Carcinoma in Hepatitis C Virus Decompensated Cirrhotic Patients with Sustained Virological Response After Antiviral Therapy.
    J Interferon Cytokine Res. 2017 Jul 21. doi: 10.1089/jir.2017.0040.
    PubMed     Abstract available


  27. BHUSHAN A, Ghosh S, Bhattacharjee S, Chinnaswamy S, et al
    Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-alpha-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
    J Interferon Cytokine Res. 2017 Jul 20. doi: 10.1089/jir.2017.0002.
    PubMed     Abstract available


    June 2017
  28. EL-MESERY M, El-Mowafy M, Elgaml A, Youssef LF, et al
    Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients.
    J Interferon Cytokine Res. 2017 Jun 13. doi: 10.1089/jir.2016.0128.
    PubMed     Abstract available


    May 2017
  29. SALUM GM, Bader El Din NG, Ibrahim MK, Anany MM, et al
    Vascular Endothelial Growth Factor Expression in Hepatitis C Virus-Induced Liver Fibrosis: A Potential Biomarker.
    J Interferon Cytokine Res. 2017 May 4. doi: 10.1089/jir.2016.0127.
    PubMed     Abstract available


    April 2017
  30. BENITO JM, Garcia-Samaniego J, Garcia M, Madejon A, et al
    Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
    J Interferon Cytokine Res. 2017 Apr 25. doi: 10.1089/jir.2016.0078.
    PubMed     Abstract available


  31. HSIAO JL, Ko WS, Shih CJ, Chiou YL, et al
    The Changed Proportion of CD45RA+/CD45RO+ T Cells in Chronic Hepatitis C Patients During Pegylated Interferon-alpha with Ribavirin Therapy.
    J Interferon Cytokine Res. 2017 Apr 17. doi: 10.1089/jir.2016.0113.
    PubMed     Abstract available


  32. SHENEEF A, Esmat MM, Mohammad AN, Mahmoud AA, et al
    Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus-Related Liver Cirrhosis Risk.
    J Interferon Cytokine Res. 2017;37:175-180.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: